Page last updated: 2024-10-29

ketamine and Corneal Injuries

ketamine has been researched along with Corneal Injuries in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Corneal Injuries: Damage or trauma inflicted to the CORNEA by external means.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Sanatkar, M2
Nozarian, Z2
Bazvand, F2
Abdi, P2
Lee, SH1
Leem, HS1
Jeong, SM1
Lee, K1

Other Studies

2 other studies available for ketamine and Corneal Injuries

ArticleYear
The effect of topical ketamine administration on the corneal epithelium repair.
    Scientific reports, 2022, 12-12, Volume: 12, Issue:1

    Topics: Administration, Topical; Animals; Cornea; Corneal Injuries; Epithelium, Corneal; Ketamine; Male; Neo

2022
The effect of topical ketamine administration on the corneal epithelium repair.
    Scientific reports, 2022, 12-12, Volume: 12, Issue:1

    Topics: Administration, Topical; Animals; Cornea; Corneal Injuries; Epithelium, Corneal; Ketamine; Male; Neo

2022
The effect of topical ketamine administration on the corneal epithelium repair.
    Scientific reports, 2022, 12-12, Volume: 12, Issue:1

    Topics: Administration, Topical; Animals; Cornea; Corneal Injuries; Epithelium, Corneal; Ketamine; Male; Neo

2022
The effect of topical ketamine administration on the corneal epithelium repair.
    Scientific reports, 2022, 12-12, Volume: 12, Issue:1

    Topics: Administration, Topical; Animals; Cornea; Corneal Injuries; Epithelium, Corneal; Ketamine; Male; Neo

2022
Bevacizumab accelerates corneal wound healing by inhibiting TGF-beta2 expression in alkali-burned mouse cornea.
    BMB reports, 2009, Dec-31, Volume: 42, Issue:12

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cornea; Corneal Inj

2009